Every recall we track for The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — 24 in all — plus the complaints and injury reports the public filed about them.
Major Pharmaceuticals recalls 100mg chlorpromazine tablets due to potential presence of N-Nitroso Desmethyl Chlorpromazine above safe limits. Consumers should contact the company for details.
Major Pharmaceuticals recalls 25mg chlorpromazine tablets due to potential presence of N-Nitroso Desmethyl Chlorpromazine above safety limits. This may pose health risks. Check your NDC 0904-7130-06, lots N01943 or N02025.
Major Pharmaceuticals recalls 25mg chlorpromazine tablets due to potential presence of N-Nitroso Desmethyl Chlorpromazine above safe limits. This may pose health risks with long-term use. Consumers should contact the company for details.
Major Pharmaceuticals recalls 50mg chlorpromazine tablets due to potential presence of N-Nitroso Desmethyl Chlorpromazine above safe limits. This may pose health risks. Check your NDC 0904-7131-61, lots N02009 & N02026, exp. 02/28/2026.
Major Pharmaceuticals recalls 200mg chlorpromazine tablets due to potential presence of N-Nitroso Desmethyl Chlorpromazine above safe limits. This may pose health risks with improper use. Contact for return instructions.
Major Pharmaceuticals recalls 100-tablet sulfamethoxazole-trimethoprim units due to foreign micro-organism in packaging. No tablets were contaminated. Consumers should contact the manufacturer for details.
Major Pharmaceuticals recalls 10-tablet sulfamethoxazole-trimethoprim packs with a foreign microorganism in packaging. No tablets were contaminated. Consumers should check product details and contact the manufacturer for guidance.
Major Pharmaceuticals recalls 12.5 mg Carvedilol Tablets due to NNCI impurity exceeding FDA limits. Affected units may pose health risks; contact for return instructions.
Major Pharmaceuticals recalls 10mg ChlorproMAZINE Hydrochloride Tablets with N-Nitroso-Desmethyl Chlorpromazine impurity above safety limits. Rx-only medication distributed in cartons of 100 tablets.
Major Pharmaceuticals recalls 2mg Tolterodine Extended-Release Capsules due to failed dissolution testing in stability checks. This may affect medication effectiveness. Check your NDC 0904-6592-04 lot numbers.
Major Pharmaceuticals recalls Potassium Chloride Extended-Release Tablets due to failed dissolution specifications. This could affect medication effectiveness. Check your product details and contact the manufacturer for instructions.
Major Pharmaceuticals recalls 2mg Lorazepam tablets due to impurities and sub-potency risks. Affected lots expired by March 2026. Consumers should not use these tablets.
Major Pharmaceuticals recalls 1mg Lorazepam tablets due to failed impurities and sub-potent drug in stability testing. Affected lots expire through 2026. Consumers should contact for details.
Major Pharmaceuticals recalls Lorazepam 0.5mg tablets due to failed impurities and sub-potent drug results from stability testing. These tablets may not contain the correct amount of active ingredient. Consumers should contact the manufacturer for details.
Major Pharmaceuticals recalls 20mg Duloxetine capsules due to potential nitrosamine impurities. This could pose health risks if consumed. Affected lots: N01530 (exp 01/2025) and N01540 (exp 01/2025).
Major Pharmaceuticals recalls 37.5mg Venlafaxine Hydrochloride extended-release capsules due to failed dissolution testing during stability checks. This medication is prescription-only and may not release properly in the body.
Major Pharmaceuticals recalls HydrALAZINE Hydrochloride 10mg tablets (Lot T04680) due to a remote possibility of temporary health effects from impurities. No immediate action needed as the risk is low.
Major Pharmaceuticals recalls Polyvinyl Alcohol 1.4% lubricating eye drops due to non-sterility risks from manufacturing facility contamination. All bottles are affected.
Major Pharmaceuticals recalls Phenytoin Oral Suspension due to failed content uniformity specifications. This may affect medication dosing accuracy. Contact for remedy details.